CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Understand what the best cash back credit cards are and how to select one that suits your financial needs. Make informed choices.
23,341 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
In stock market today, june, BlackBerry delivered a powerful earnings beat that sparked a rally in its shares. This p...
Explore how Fluent's Q1 2026 earnings could shape its year ahead. This article breaks down revenue trends, margins, a...
Capricor is at a crossroads as 2026 earnings season unfolds. This article breaks down what to look for in capricor (c...
SoundHound AI trades in a fast-moving AI landscape with big growth potential and meaningful risks. This piece breaks ...
Want real estate exposure without being a landlord? This lazy investor’s guide real explores how syndications let you...
Looking ahead five years, a disciplined approach to income can shine. This article outlines two dependable dividend s...
When the next earnings season looms, a single well-chosen tech stock can outshine a broad, aimless portfolio. Learn h...
Talkspace stock surged today as investors responded to stronger-than-expected results and improving unit economics. T...
Discover what Universal (UVV) 2026 earnings mean for investors. This plain-English guide breaks down performance driv...
Snow-season demand shapes profitability for snow equipment makers. This article breaks down douglas dynamics (plow) e...
As investors scan headlines in June, Comcast's bold $8 billion UK theme park plan stands out. This article explains w...